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Abstract: There is concern that egg intake may increase blood glucose in patients with type
2 diabetes mellitus (T2DM). However, we have previously shown that eggs reduce
inflammation in patients at risk for T2DM, including obese subjects and those with metabolic
syndrome. Thus, we hypothesized that egg intake would not alter plasma glucose in T2DM
patients when compared to oatmeal intake. Our primary endpoints for this clinical
intervention were plasma glucose and the inflammatory markers tumor necrosis factor
(TNF)-α and interleukin 6 (IL-6). As secondary endpoints, we evaluated additional
parameters of glucose metabolism, dyslipidemias, oxidative stress and inflammation.
Twenty-nine subjects, 35–65 years with glycosylated hemoglobin (HbA1c) values <9% were
recruited and randomly allocated to consume isocaloric breakfasts containing either one
egg/day or 40 g of oatmeal with 472 mL of lactose-free milk/day for five weeks. Following
a three-week washout period, subjects were assigned to the alternate breakfast. At the end of
each period, we measured all primary and secondary endpoints. Subjects completed
four-day dietary recalls and one exercise questionnaire for each breakfast period. There were
no significant differences in plasma glucose, our primary endpoint, plasma lipids, lipoprotein
size or subfraction concentrations, insulin, HbA1c, apolipoprotein B, oxidized LDL or
C-reactive protein. However, after adjusting for gender, age and body mass index, aspartate
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amino-transferase (AST) (p < 0.05) and tumor necrosis factor (TNF)-α (p < 0.01), one of our
primary endpoints were significantly reduced during the egg period. These results suggest
that compared to an oatmeal-based breakfast, eggs do not have any detrimental effects on
lipoprotein or glucose metabolism in T2DM. In contrast, eggs reduce AST and TNF-α in
this population characterized by chronic low-grade inflammation.
Keywords: diabetes; eggs; lipoproteins; TNF-α; IL-6; glucose; inflammation

1. Introduction
Epidemiological studies report controversies on the effects of dietary cholesterol and egg intake on
the risk for heart disease in patients with diabetes [1,2]. There is also uncertainty regarding the
associations between dietary cholesterol and the development of diabetes [3,4]. While some
epidemiological studies report a correlation between dietary cholesterol and diabetes risk [5,6], others
fail to find this relationship [3,7]. Thus, there is a need for randomized clinical trials to fully understand
the effects of egg intake on plasma glucose and markers of heart disease risk in patients diagnosed with
type 2 diabetes mellitus (T2DM). Individuals with T2DM are characterized by having impaired glucose
metabolism, atherogenic dyslipidemia [8], and chronic low-grade inflammation [9], therefore,
recommended foods for diabetic patients should either improve, or have no detrimental effect on
biomarkers associated with these conditions.
Oatmeal is recognized as a heart-healthy breakfast due to the effects of β-glucan on reducing plasma
LDL cholesterol (LDL-C) [10]. Oatmeal has also been shown to decrease blood glucose in 14 patients with
uncontrolled T2DM [11]. In contrast, eggs are identified as a food that might raise plasma LDL-C [12],
or that could potentially alter glucose metabolism and lead to diabetes [13].
It has been documented that the Latino population has a genetic predisposition for developing
T2DM [14]. In Mexico, 35.7 and 37.2% of adults ≥20 years old are overweight and obese, respectively—a
dramatic increase from 2006 (26 and 29%) [15]. This obesity epidemic, combined with the genetic
predisposition of Latinos for developing T2DM, contributes to one of the highest incidences of diabetes
worldwide [16], with the northern state of Sonora having one of the greatest rates of diabetes in the
country [17].
We aimed to compare two breakfasts with perceived differences in effects on heart disease risk, eggs
and oatmeal, by conducting a randomized, crossover clinical trial in subjects with T2DM. We evaluated
the effects of consuming one egg per day for a relatively extended period (five weeks) versus 1/2 cup
(40 g) of oatmeal per day on plasma glucose and inflammatory markers, our primary endpoints. Our
secondary endpoints included plasma lipids, markers of oxidative stress, and parameters of glucose
metabolism, such as glycosylated hemoglobin (HbA1c). We hypothesized that eating one egg per day
would not adversely affect primary or secondary endpoints when compared to an oatmeal breakfast. We
further hypothesized that eggs would reduce inflammatory markers in this population, likely due to the
presence of highly bioavailable carotenoids [18]. Due to the high rate of diabetes, in combination with
the fact that Mexico is one of the countries that consumes most eggs per capita (approx. one
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egg/person/day) [19], we chose our intervention population from the city of Hermosillo, Sonora to
conduct this clinical trial.
2. Experimental Section
2.1. Experimental Design
We recruited 33 subjects (aged 35–65 years) diagnosed with T2DM to participate in this randomized
crossover design study in the city of Hermosillo, Mexico. Based on the standard deviation from our
previous studies where we observed changes in inflammatory markers and using a Z value of 1.96
(95% confidence interval), we estimated that 25 subjects would be sufficient to observe differences
between groups [20,21]. We aimed to recruit 35 subjects to allow for attrition. The study took place
between June–December 2013, from the first subject who was enrolled to study completion by the last
enrolled participant. The exclusion criteria were uncontrolled diabetes, retinopathy, heart disease,
cancer, or renal problems. In addition, participants had to have HbA1c <9% (74.9 mmol/mol). On an
alternating basis, participants were randomly allocated by one of the researchers to consume either one
egg/day or 40 g of oatmeal with 2 cups (472 mL) of lactose-free milk/day for 5 weeks. At the end of the
first period, subjects had a 3-week washout followed by allocation to the alternate breakfast for an
additional 5 weeks. Eggs, oatmeal and lactose-free milk were provided to the subjects every 2 weeks
and they returned the uneaten portions, which were recorded by the researchers. Compliance for both
breakfasts was 98 ± 2%. Eggs were purchased from Bachoco, Inc. (Hermosillo, Mexico). Eggs weighed
an average of 65 g and contained 8 g protein, 6.8 g fat and 0.3 g carbohydrate. The content of cholesterol
was 250 mg and lutein was 180 μg as previously determined [22]. Oatmeal (Quaker oatmeal) was
purchased from the local super-market. The average consumption was 1/2 measured cup (40 g)
consisting of 5.5 g protein, 3.6 g fat, 23.6 g of total carbohydrate; total fiber was 3.2 g and soluble fiber
0.85 g. Subjects were provided with measuring cups for the oatmeal and they were told not to consume
oatmeal or eggs during the whole intervention except those provided by the researchers. Subjects were
closely monitored by random phone calls to ensure compliance. All analysis for the study, including
experimental analysis of primary and secondary endpoints, were conducted by researchers who were
blinded to breakfast allocation.
Twenty-nine subjects finished both dietary interventions. Three subjects dropped out of the study due
to personal reasons and 1 subject was removed due to non-compliance with the dietary treatments.
In order to maintain control of T2DM, all subjects were taking glucose-lowering medications, as
prescribed by their physician, including metmorfin (n = 26) and insulin (n = 6). In addition, 18 subjects
were taking blood pressure medication and 9 were on reductase inhibitors. The intervention protocol
was approved by the University of Connecticut Institutional Review Board, the Ethical Committee from
Centro de Investigacion en Alimentacion y Desarrollo (CIAD), and the Review Board from Hospital
Chávez. All subjects gave written informed consent prior to initiating the study. This study is registered
at Clinicaltrials.gov (trial # NCT02181244)
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2.2. Diet and Exercise Assessment
Diet was assessed by using four 24-h dietary recalls at the end of each breakfast period, which
included 2 weekdays and 2 weekend days. Subjects were visited by trained dietitians, who interviewed
the subjects to complete all dietary recalls. Nutrient analysis was conducted utilizing ESHA Food
Processor II, version 2007, to which typical diets associated with this region in Mexico have been added.
Subjects received specific instructions to include all foods and ingredients in their dietary recall, in
addition to their respective breakfast foods during the intervention. Participants were instructed to
abstain from consuming oatmeal or eggs during the whole 13-week of the intervention, with the
exception of treatment foods provided by the researchers. A typical breakfast consisted of either one
egg, usually scrambled, accompanied by vegetables and 2 slices of bread or 2 tortillas, or 40 g of oatmeal
with 2 cups (472 mL) of lactose-free milk. We provided lactose-free milk to control for potential lactose
intolerance, which is very common in adults from Hispanic origin. The average amount of calories
consumed for breakfast was 313 kcal/day for the egg period and 335 kcal/day for the oatmeal period. An
exercise diary was also provided to subjects to ensure that there were no changes in their activity level
during the interventions. Subjects provided 3 exercise dairies at the end of each breakfast period. All
participants were very closely monitored by their physician (HV) throughout the whole study to ensure
that they did not change their medications. They were also monitored by the researchers to ensure
compliance with egg and oatmeal intake, and to ascertain that they did not change the rest of their dietary
habits or their level of physical activity during the 13-week intervention.
2.3. Anthropometrics, Body Fat and Blood Pressure
Weight was measured to the nearest 0.1 kg, height was measured to the nearest centimeter, and body
mass index (BMI) was calculated as kg/m2. Body fat was measured by electric bioimpedance using an
Impedimed IMP5™ (Impedimed Pty Ltd, Carlsbad, CA, USA). Blood pressure was measured with an
automated blood pressure monitor (Desk Model Sphingomanometer, Model 100, Bannockburn, IL,
USA) after a 5 min rest. The average of 3 separate recordings is reported.
2.4. Plasma Lipids, Oxidized-LDL and Apolipoprotein B
Subjects fasted 12 h prior to blood draws. Plasma was separated from red blood cells by centrifugation
at 2400× g to measure plasma total cholesterol (TC), LDL (LDL-C), HDL (HDL-C) and triglycerides
by using the Cobas c-111 Clinical Analyzer (Roche Diagnostics, Indianapolis, IN, USA). Oxidized-LDL
was measured by using an ELISA kit from Mercodia (Uppsala, Sweden) and Apolipoprotein B by
utilizing an ELISA kit from Abcam (Cambridge, MA, USA).
2.5. Glucose, Insulin and Homeostatic Mode Assessment (HOMA)
Fasting glucose concentrations, one of our primary endpoints, was analyzed by an enzymatic
colorimetric method (Roche Diagnostics, Indianapolis, IN, USA). Plasma insulin was determined with
an ELISA method (ALPCO Diagnostics, Salem, NH, USA). The homeostasis model assessment
(HOMA) was used to calculate insulin resistance [23]. HbA1c was measured by utilizing an
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immunoturbidimetric method standardized by the National Glycohemoglobin standardization program
(Roche Diagnostics, Indianapolis, IN, USA).
2.6. Determination of Size and Concentrations of VLDL, LDL and HDL Subfractions
Lipoprotein subclass profiles and diameters were measured by proton NMR spectroscopy as
previously reported [24]. This method uses characteristic signals broadcast by lipoprotein subclasses of
different size.
2.7. Inflammatory Markers, Liver Enzymes and Adiponectin
Alanine aminotransferase (ALT), aspartate aminotransferase (AST), and C-reactive protein (CRP)
were measured using the Cobas c-111 Clinical Analyzer. Interleukin-6 (IL-6) and tumor necrosis
factor-α (TNF-α), the other two primary endpoints, were measured utilizing ELISA kits (BD
Biosciences, San Jose, CA, USA). Adiponectin was measured by using a Quantikine ELISA by RD
Systems Inc. (Minneapolis, MN, USA).
2.8. Statistical Analysis
SPSS version 13.2 was used for Statistics. A paired t-test was used to evaluate differences in all
measured parameters between the oatmeal and the egg periods. Values are reported as mean ± SD.
A p-value < 0.05 was considered to be significant. Those parameters that were significantly different by
paired t-test were further analyzed by using gender, age and initial BMI as covariates.
3. Results
3.1. Flow Chart of the Study
As indicated in Figure 1, we consented 37 patients for this study. Four of them were excluded because
they did not meet the inclusion/exclusion criteria. From these four, three had HbA1c levels >9%, and
one did not have diabetes as determined by blood glucose levels and glucose tolerance tests. The
33 patients who met the inclusion criteria were randomly allocated to consume eggs (n = 16) or oatmeal
(n = 17). Before the crossover, three patients decided not to continue the study and one was removed by
the investigators due to non-compliance. Twenty-nine patients finished the whole intervention. All
measured variables presented are for these 33 patients.

Nutrients 2015, 7

3454

Figure 1. Flow chart of the study.
3.2. Baseline Characteristics
The baseline characteristics of subjects are presented in Table 1. The average age of this population
was 53.5 years and the gender distribution was 19 females and 10 males. The mean value for HbA1c
was 6.75% (50 mmol/mol) indicating good average glycemic control in this population. Seven subjects
were taking statins and 18 subjects were taking hypotensive medications. The majority of subjects
(n = 27) had plasma TC < 2.5 mmol/L, LDL-C < 1.2 mmol/L, and blood pressure < 130/85 mmHg.
Plasma triglycerides were high with a mean 2.2 ± 1.2 mmo/L, typical of a diabetic population.
Table 1. Baseline Characteristics of Subjects *.
Parameter (n = 29)
Age (years)
Gender (n = F/M)
Total Cholesterol (mmol/L)
LDL Cholesterol (mmol/L)
Triglycerides (mmol/L)
HDL Cholesterol (mmol/L)
LDL-C/HDL-C
Glucose (mmol/L)

Values
53.5 ± 8.3
19/10
4.1 ± 0.7
2.3 ± 0.6
2.2 ± 1.0
1.0 ± 0.2
2.4 ± 1.1
9.0 ± 3.1

Glycosylated Hemoglobin (%) (mmol/L)

6.75 ± 0.89
(50 ± 9.7)

* Values are presented as mean ± SD; n = 29.
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3.3 Primary end Points
Results for the primary endpoints are presented in Figure 2. There were no differences in plasma
glucose concentrations between the egg and oatmeal periods (Figure 2A). Similarly, there was a
significant reduction in TNF-α, the other primary endpoints after the egg breakfast period, while IL-6
was, was borderline significant (p = 0.051). (Figure 2B).

Figure 2. Plasma concentrations of glucose (A) and plasma concentrations of interleukin 6
(IL-6) and tumor necrosis factor-α (TNF-α) (B) after the egg (dark bar) and the oatmeal
(white bar). Mean values for plasma glucose were 9.0 ± 3.0 mmol/L and 8.8 ± 2.3 mmol/L
after the oatmeal periods. IL-6 were 3.8 ± 2.7 pg/mL following the egg breakfast (p = 0.051)
and 5.2 ± 4.8 pg/mL after the oatmeal and for TNF-α were 6.7 ± 2.8 pg/mL after the egg
breakfast (p = 0.007) and 7.9 ± 2.7 pg/mL after the oatmeal. *Indicates significantly different
p < 0.05 and ** p < 0.01. NS = non-significant.
3.4. Diet
Dietary intake in egg and oatmeal periods is presented in Table 2. Total energy and percent energy
from protein were not different between periods. In contrast, percent energy from carbohydrate was
higher in the oatmeal period (p < 0.01), while percent of energy from total fat, and saturated, monounsaturated
and polyunsaturated fatty acids (g) were higher during the egg period (p < 0.001). Total and soluble fiber
intake was higher during the oatmeal period (p < 0.01), while dietary cholesterol was higher during the
egg period (p < 0.01) (Table 2). Interestingly, intakes of lutein and zeaxanthin, the carotenoids present
in eggs, were not different between dietary periods (Table 2).
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Table 2. Dietary intake during Egg and Oatmeal Periods *.

Parameter
Energy (Kcal)
Protein (%)
Carbohydrate (%)
Total Fat (%)
SFA (g/day)
MUFA (g/day)
PUFA (g/day)
Total Fiber (g/day)
Soluble Fiber (g/day)
Insoluble Fiber (g/day)
Cholesterol (mg/day)
Lutein + Zeaxanthin (μg/day)
Glycemic Index
Glycemic Load

Egg
1629 ± 410
18.9 ± 3.5
50.3 ± 6.5
31.6 ± 5.6
21.0 ± 8.9
17.0 ± 5.3
8.1 ± 2.4
26.0 ± 10.1
5.2 ± 3.3
13.3 ± 5.6
435.0 ± 119.8
1213 ± 1731
49.2 ± 8.7
17.3 ± 9.4

Oatmeal
1686 ± 362
20.0 ± 3.5
55.1 ± 7.3
24.7 ± 6.8
17.3 ± 9.4
12.8 ± 6.6
6.3 ± 2.8
27.5 ± 9.2
6.7 ± 3.1
15.2 ± 5.7
149.4 ± 77
1003 ± 1742
48.5 ± 7.7
17.1 ± 21.3

p Value
0.278
0.134
0.010
<0.0001
0.043
0.006
0.009
0.345
0.008
0.073
<0.0001
0.185
0.752
0.828

* Values are presented as mean ± SD; n = 29 subjects.

3.5. Anthropometrics, Blood Pressure, Plasma Lipids, HbA1c and Insulin
There were no significant differences in body weight, body fat, BMI or blood pressure between the
egg and oatmeal periods (Table 3). Similarly, body weight was not different from baseline or the washout
period (data not shown). While only nine subjects were taking blood pressure medications, all subjects
had systolic and diastolic blood pressure < 130/85 mmHg. Similarly, there were no significant
differences in TC, LDL-C, HDL-C, triglycerides, LDL-C/HDL-C ratio, apolipoprotein B, Ox-LDL,
HbA1c, insulin and insulin resistance measured by HOMA when comparing the egg versus oatmeal
periods (Table 3). Values for anthropometrics, plasma lipids, glucose and HbA1c were not different
between baseline and washout periods (p > 0.05) (data not shown).
3.6. Lipoprotein Number and Subclasses
There were no differences in total lipoprotein number or concentrations of lipoprotein subclasses
between the egg and the oatmeal periods including the atherogenic lipoproteins large VLDL, IDL and
small LDL (Table 4).
3.7. CRP and Liver Enzymes
CRP (6.96 ± 10.15 vs. 6.87 ± 8.98 mg/L), adiponectin (6.2 ± 3.2 vs. 5.6 ± 2.2 μg/mL), and ALT
24.3 ± 11.7 vs. 26.3 ± 13.0 IU/L) were not different when compared at the end of egg and oatmeal
periods, respectively. However, AST was significantly reduced following the egg period (p < 0.05). Data
for liver enzymes is presented in Figure 3.
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Table 3. Anthropometrics, Blood Pressure (BP), Plasma Lipids, Oxidized LDL,
Apolipoprotein B, Glucose, Glycosylated Hemoglobin, Insulin and HOMA after the Egg and
Oatmeal Breakfasts *.
Parameter (n = 29)
Weight (kg)
BMI (kg/m2)
Body Fat (%)
Systolic BP (mmHg)
Diastolic BP (mmHg)
Total cholesterol (mmol/L)
LDL cholesterol (mmol/L)
Triglycerides (mmol/L)
HDL cholesterol (mmol/L)
LDL-C/HDL-C
Apolipoprotein B (mg/L)
Oxidized LDL (U/L)
Glycosylated Hemoglobin (%)
Insulin (pmol/L)
HOMA

Egg
82.1 ±17.0
30.8 ± 6.4
45 ± 9
123.5 ± 11.1
76.1 ± 7.4
4.1 ± 1.5
2.5 ± 0.6
1.48 ± 0.47
1.17 ± 0.23
1.99 ± 0.72
90.8 ± 33.9
76.9 ± 25.3
6.55 ± 0.93
101.4 ± 63.2
3.7 ± 0.7

Oatmeal
82.1 ± 17.1
30.8 ± 6.5
44 ± 8
123.8 ± 11.3
76.1 ± 8.0
4.0 ± 0.8
2.4 ± 0.6
1.53 ± 0.55
1.14 ± 0.21
1.95 ± 0.68
95 ± 38
80.6 ± 32.7
6.60 ± 1.04
86.8 ± 50.7
3.1 ± 0.6

* Values are presented as mean ± SD. There were no significant differences between groups in any of these
parameters as measured by paired t-test.

Table 4. Concentrations of VLDL, IDL, LDL, and HDL subclasses after the egg and oatmeal
breakfasts *.
Parameter (n = 29)
Total VLDL Particles (mmo/L)
Large VLDL (mmol/L)
Medium VLDL (mmol/L)
Small VLDL(mmol/L)
Total LDL (mmol/L)
Large LDL(mmol/L)
Small LDL(mmol/L)
IDL(mmol/L)
Total HDL Particles (µmol/L)
Large HDL(μmol/L)
Medium HDL(μmol/L)
Small HDL(μmol/L)

Egg
53.8 ± 27.7
7.0 ± 4.5
21.9 ± 12.3
24.9 ±17.6
1117 ± 290
189 ± 147
775 ± 251
152 ± 89
32.7 ± 5.8
3.74 ± 1.88
8.21 ± 5.33
20.71 ± 3.71

Oatmeal
53.1 ± 26.4
7.6 ± 5.1
21.6 ± 13.5
23.8 ± 13.1
1064 ± 253
215 ± 141
715 ± 230
134 ± 103
33.2 ± 6.3
3.64 ± 1.98
8.34 ± 5.41
21.17 ± 3.94

* Values are presented as mean ± SD. There were no significant differences between groups in any of these
parameters as measured by paired t-test.
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Figure 3. Concentrations of liver enzymes after the egg (dark bar) and the oatmeal (white
bar) periods. ALT did not differ between treatments; However, AST was significantly
reduced (p < 0.05) after the egg period (21.9 ± 5.8 vs. 23.7 ± 6.4 IU/L)
4. Discussion
In this very well-controlled randomized, crossover clinical trial, we have demonstrated that
consuming 1 egg per day for breakfast during 5 weeks did not alter plasma glucose one of the primary
end points. This is a key finding in regards to the current controversies of egg intake affecting plasma
glucose levels in individuals with diabetes [3,4]. Further, our results have shown that consuming 1 egg
per day could be considered potentially beneficial for this population as documented by the observed
reductions in the inflammatory marker, TNF-α, the other primary end point, when compared to
consumption of oatmeal.
We have also demonstrated that consuming 1 egg per day for breakfast during 5 weeks did not alter
plasma lipids, atherogenic lipoproteins, other parameters of glucose metabolism and CRP when
compared to an oatmeal-based breakfast in individuals diagnosed with T2DM. We have previously
shown that 4 weeks is sufficient time to see lipid changes following dietary egg challenges [25,26].
For this study, we followed subjects for an additional week, yet still observed no modifications in
plasma lipids.
This is one of the first clinical trials in which egg effects on cholesterol and glucose metabolism were
determined in a compromised population characterized by having dyslipidemias, insulin resistance and
elevated concentrations of plasma inflammatory markers. The results suggest that egg intake (one per
day) can be easily incorporated into the diets of patients with T2DM, with no apparent concerns for
causing dysregulation of glucose metabolism or formation of atherogenic particles. The beneficial
effects on inflammatory markers confirm what we have observed in past studies regarding the effects of
eggs in decreasing inflammation in other populations at high risk for heart disease and diabetes,
including obesity [20] and metabolic syndrome [21]. In a recent clinical trial, high and low cholesterol
diets were compared in 65 individuals with T2DM [27]. Similar to our design, authors used eggs as a
source of dietary cholesterol and they reported that the egg diet was more effective in improving
glycemic control and the lipid profile by raising HDL-C [27].
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Oatmeal has been shown to decrease LDL-C in healthy and hypercholesterolemic individuals [28] in
clinical trials, possibly due to the presence of β-glucan, a component present in oats that has been shown
to lower cholesterol by disrupting micelle formation and decreasing absorption of dietary cholesterol
and bile acids [29]. Thus, it is well recognized that oatmeal is a “heart healthy” food that is recommended
for all populations, including diabetic subjects [30]. In contrast, due to the high content of dietary
cholesterol, eggs have been identified as a food that should be avoided not only in diseased patients, but
also in healthy populations [31]. We have previously demonstrated that consumption of two to three eggs
per day for periods between 4 to 12 weeks does not increase the risk profile for heart disease in healthy
populations [25,26,32]. Most of our subjects (about 2/3 of the population) do not experience fluctuations
in plasma cholesterol following a dietary cholesterol challenge. For those who have increases in plasma
total cholesterol, both LDL-C and HDL-C raise with maintenance of the LDL-C/HDL-C ratio [25,26,32].
Further, during weight loss interventions, plasma LDL-C does not change even after consuming
three eggs per day during 12 weeks, while HDL-C increases with an improvement of the LDL-C/HDL-C
ratio [20,21].
Contrary to the findings of Pearce et al. [27], who were using a high protein, energy-restricted diet,
our current study found that neither LDL-C nor HDL-C were altered by the egg breakfast when
compared to the oatmeal breakfast, an interesting finding due to the documented effect of oatmeal in
lowering LDL-C [27]. Although we have previously shown that egg intake increases the formation of
large HDL, which has been postulated to promote reverse cholesterol transport [33], and the formation
of large LDL, a particle that has been suggested to be less atherogenic [34], we failed to observe any
changes in LDL or HDL size between dietary periods in these diabetic patients.
These results indicating a lack of effect of egg and oatmeal consumption on plasma lipids and lipoproteins
may be attributable to several factors. In our previous studies, we challenged our subjects with two to
three eggs per day [25,26,32], whereas this current study evaluated the effect of consuming only one egg
per day; thus, the higher concentrations of both cholesterol and egg phospholipids provided in our
previous studies may be related to the formation of the larger lipoprotein particles [34,35]. Another
interpretation is that diabetes substantially alters lipoprotein metabolism [36], and consumption of one
egg per day was not sufficient to reverse these metabolic abnormalities. Although the number of large
and small LDL particles found in this study are similar to those observed in overweight/obese [35]
and metabolic syndrome [21,37] populations, the concentrations of intermediate-density lipoprotein
(IDL) and large VLDL are higher in this study compared to previous observations in other high-risk
populations [21,35,37]. The higher levels of IDL could be associated with the hypertriglyceridemia that is
common in diabetes [36], which can lead to the formation of more IDL and large atherogenic
VLDL particles.
In addition to maintaining fasting plasma glucose levels, our main finding in this study is that
TNF-α and AST were reduced following the 5-week, one-egg-per-day breakfast. Chronic low-grade
inflammation is a hallmark of diabetes and diabetic patients are characterized by having elevated
concentrations of inflammatory markers [9]; thus, the observed reductions in plasma concentrations of
AST and TNF-α following egg intake deserve further consideration, and may be explained by the
presence of lutein and zeaxanthin in egg yolk. Although intake of these dietary carotenoids was not
different between dietary periods, we have previously shown that plasma concentrations of lutein and
zeaxanthin are significantly higher when eggs are the dietary source [38]. This is likely due to the higher
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bioavailability of egg-derived carotenoids [22]. In addition, lutein and zeaxanthin have been shown to
have anti-oxidative and anti-inflammatory properties in cell studies [39], animal models [40] and
humans [20,21]. The results from the current study highlight the importance of certain dietary carotenoids
that could exert a protective effect against inflammation in those populations characterized by having
chronic low-grade inflammation, as is the case of patients with diabetes.
The main strength of this study is that it was a controlled clinical intervention. We performed thorough
dietary recalls and ensured that subjects did not change their activity level during the intervention period.
We also provided the intervention foods and monitored consumption. In addition, the recruited subjects
had good diabetic control as monitored by their HbA1c plasma concentrations, as well as the absence of
extreme diabetes complications, which was a key element for subject compliance. Further, we ensured
that subjects did not change their medication dose/type during the 13-week intervention. The weaknesses
of this study include the short duration of the trial, which might not have been sufficient to determine
changes in some of the measured parameters, and the fact that the data cannot be extrapolated for those
diabetic patients with uncontrolled diabetes or additional complications associated with T2DM. Another
perceived weakness is the lack of blinding of the subjects and that no intention to treat analysis
was performed.
5. Conclusions
In this study, we have shown that eggs should not be a concern for those individuals with T2DM
when HbA1c levels are well controlled. When compared to an oatmeal breakfast, one egg per day did
not result in changes in plasma glucose, our primary end point, LDL-C, triglycerides or in the concentration
of atherogenic particles including large VLDL, IDL or small LDL. Further, there were no changes in
plasma insulin, HOMA or HbA1c, indicating that eggs can be consumed without any detrimental changes
in lipoprotein or glucose metabolism in this population. The most interesting finding, however, was that
eggs—possibly due to their content of highly bioavailable lutein and zeaxanthin—reduced inflammation
in diabetic subjects when compared to oatmeal intake.
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